Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

278.35
-2.4100-0.86%
Post-market: 278.350.00000.00%19:30 EDT
Volume:789.22K
Turnover:219.27M
Market Cap:13.29B
PE:-57.02
High:280.75
Open:278.54
Low:275.00
Close:280.76
52wk High:303.31
52wk Low:144.26
Shares:47.74M
Float Shares:47.20M
Volume Ratio:1.15
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8814
EPS(LYR):-2.9122
ROE:-7.52%
ROA:4.11%
PB:4.68
PE(LYR):-95.58

Loading ...

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Yesterday

Charles River implements Endosafe Cartridge Technology Automated Manufacturing

TIPRANKS
·
Sep 08

Charles River Expands Endosafe Cartridge Output with Automated Manufacturing Suite

Reuters
·
Sep 08

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

How Investors Are Reacting To Charles River (CRL) Deepening Its Role In Complex Vaccine Development

Simply Wall St.
·
Sep 03

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Charles River Laboratories International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Sep 01

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Charles River Director James C. Foster Disposes of USD 10.07 Million in Common Shares

Reuters
·
Aug 28

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 25

Is Charles River (CRL) Quietly Redefining Its Edge Through Complex Biologics and Vaccine Testing?

Simply Wall St.
·
Aug 23

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 22

Charles River Labs Director Nancy C. Andrews Disposes of 573 Common Shares Worth $163,442.52

Reuters
·
Aug 21

Charles River Partners with Medigen Vaccine Biologics on NGS-Backed Multivalent Enterovirus Vaccine Development

Reuters
·
Aug 20

Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing

THOMSON REUTERS
·
Aug 20

How an Insider CEO is Taking a Fresh Look at Charles River

Dow Jones
·
Aug 20

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

GlobeNewswire
·
Aug 20

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 20

Charles River Laboratories International (CRL) Cut 2026 Guidance, Is The Stock Still 11% Undervalued?

Simply Wall St.
·
Aug 19

Charles River Laboratories International Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 18